{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:14:38Z","timestamp":1790018078693,"version":"4.0.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T00:00:00Z","timestamp":1592352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Spanish Carlos III Institute of Health","award":["CP14\/00198"],"award-info":[{"award-number":["CP14\/00198"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00109-020-01930-x","type":"journal-article","created":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T21:03:50Z","timestamp":1592427830000},"page":"1093-1105","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Transcriptional signature of resting-memory CD4 T cells differentiates spontaneous from treatment-induced HIV control"],"prefix":"10.1007","volume":"98","author":[{"given":"Marcial","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mor\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A","family":"Navarrete-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"L\u00f3pez-Bernaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bengur\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Fern\u00e1ndez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"De la Hera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00ednez-Picado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"G\u00f3rgolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7172-049X","authenticated-orcid":false,"given":"Jos\u00e9 M.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4643-247X","authenticated-orcid":false,"given":"Norma","family":"Rall\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,17]]},"reference":[{"key":"1930_CR1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/387188a0","volume":"387","author":"AS Perelson","year":"1997","unstructured":"Perelson AS, Essunger P, Cao Y, Vesanen M, Hurley A, Saksela K, Markowitz M, Ho DD (1997) Decay characteristics of HIV-1-infected compartments during combination therapy. Nature 387:188\u2013191","journal-title":"Nature"},{"key":"1930_CR2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","volume":"362","author":"C Katlama","year":"2003","unstructured":"Katlama C, Kirk O, Reiss P, d\u2019Arminio Monforte A, Knysz B, Dietrich M, Phillips AN, Lundgren JD et al (2003) Decline in the AIDS and death rates in the EuroSIDA study: an observational study. Lancet 362:22\u201329","journal-title":"Lancet"},{"key":"1930_CR3","doi-asserted-by":"crossref","first-page":"F79","DOI":"10.1097\/00002030-199711000-00002","volume":"11","author":"MD de Jong","year":"1997","unstructured":"de Jong MD, de Boer RJ, de Wolf F, Foudraine NA, Boucher CA, Goudsmit J, Lange JM (1997) Overshoot of HIV-1 viraemia after early discontinuation of antiretroviral treatment. AIDS 11:F79\u2013F84","journal-title":"AIDS"},{"key":"1930_CR4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/77481","volume":"6","author":"TW Chun","year":"2000","unstructured":"Chun TW, Davey RT Jr, Ostrowski M, Shawn Justement J, Engel D, Mullins JI, Fauci AS (2000) Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med 6:757\u2013761","journal-title":"Nat Med"},{"key":"1930_CR5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/QAD.0000000000000987","volume":"30","author":"R Calin","year":"2016","unstructured":"Calin R, Hamimi C, Lambert-Niclot S, Carcelain G, Bellet J, Assoumou L, Tubiana R, Calvez V, Dudoit Y, Costagliola D (2016) Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir. AIDS 30:761\u2013769","journal-title":"AIDS"},{"key":"1930_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nature16933","volume":"530","author":"R Lorenzo-Redondo","year":"2016","unstructured":"Lorenzo-Redondo R, Fryer HR, Bedford T, Kim EY, Archer J, Kosakovsky SLK, Chung YS, Penugonda S, Chipman J, Fletcher CV (2016) Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530:51\u201356","journal-title":"Nature"},{"key":"1930_CR7","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1073\/pnas.94.24.13193","volume":"94","author":"TW Chun","year":"1997","unstructured":"Chun TW, Stuyver L, Mizell SB, Ehler LA, Mican JA, Baseler M, Lloyd AL, Nowak MA, Fauci AS (1997) Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc Natl Acad Sci USA 94:13193\u201313197","journal-title":"Proc Natl Acad Sci USA"},{"key":"1930_CR8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","volume":"278","author":"JK Wong","year":"1997","unstructured":"Wong JK, Hezareh M, G\u00fcnthard HF, Havlir DV, Ignacio CC, Spina CA, Richmann (1997) Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 278:1291\u20131295","journal-title":"Science"},{"key":"1930_CR9","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","volume":"278","author":"D Finzi","year":"1997","unstructured":"Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R et al (1997) Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295\u20131300","journal-title":"Science"},{"key":"1930_CR10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.tim.2016.01.006","volume":"24","author":"K Barton","year":"2016","unstructured":"Barton K, Winckelmann A, Palmer S (2016) HIV-1 Reservoirs during suppressive therapy. Trends Microbiol 24:345\u2013355","journal-title":"Trends Microbiol"},{"key":"1930_CR11","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1981","volume":"28","author":"M Garc\u00eda","year":"2018","unstructured":"Garc\u00eda M, Buz\u00f3n MJ, Benito JM, Rall\u00f3n N (2018) Peering into the HIV reservoir. Rev Med Virol 28:e1981","journal-title":"Rev Med Virol"},{"key":"1930_CR12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","volume":"9","author":"JD Siliciano","year":"2003","unstructured":"Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, Kovacs C, Gange SJ, Siliciano RF (2003) Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med 9:727\u2013728","journal-title":"Nat Med"},{"key":"1930_CR13","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1073\/pnas.95.15.8869","volume":"95","author":"TW Chun","year":"1998","unstructured":"Chun TW, Engel D, Berrey MM, Shea T, Corey L, Fauci AS (1998) Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc Natl Acad Sci USA 95:8869\u20138873","journal-title":"Proc Natl Acad Sci USA"},{"key":"1930_CR14","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1120248109","volume":"109","author":"NM Archin","year":"2012","unstructured":"Archin NM, Vaidya NK, Kuruc JD, Liberty AL, Wiegand A, Kearney MF, Cohen MS, Coffin JM, Bosch RJ, Gay CL (2012) Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci USA 109:9523\u20139528","journal-title":"Proc Natl Acad Sci USA"},{"key":"1930_CR15","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","volume":"5","author":"D Finzi","year":"1999","unstructured":"Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C et al (1999) Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med 5:512\u2013517","journal-title":"Nat Med"},{"key":"1930_CR16","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/QAD.0000000000000295","volume":"28","author":"A de Masson","year":"2014","unstructured":"de Masson A, Kirilovsky A, Zoorob R, Avettand-Fenoel V, Morin V, Oudin A, Descours B, Rouzioux C, Autran B (2014) Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers. AIDS 28:1567\u20131577","journal-title":"AIDS"},{"key":"1930_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","volume":"15","author":"N Chomont","year":"2009","unstructured":"Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM et al (2009) HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 15:893\u2013900","journal-title":"Nat Med"},{"key":"1930_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-4690-10-11","volume":"10","author":"DA Donahue","year":"2013","unstructured":"Donahue DA, Wainberg MA (2013) Cellular and molecular mechanisms involved in the establishment of HIV-1 latency. Retrovirology 10:11","journal-title":"Retrovirology"},{"key":"1930_CR19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1172\/JCI80142","volume":"125","author":"GM Laird","year":"2015","unstructured":"Laird GM, Bullen CK, Rosenbloom DI, Martin AR, Hill AL, Durand CM, Siliciano JD, Siliciano RF (2015) Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations. J Clin Invest 125:1901\u20131912","journal-title":"J Clin Invest"},{"key":"1930_CR20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005063","volume":"11","author":"G Darcis","year":"2015","unstructured":"Darcis G, Kula A, Bouchat S, Fujinaga K, Corazza F, Ait-Ammar A, Delacourt N, Melard A, Kabeya K, Vanhulle C et al (2015) An in-depth comparison of latency-reversing agent combinations in various in vitro and ex vivo HIV-1 latency models identified bryostatin-1+JQ1 and ingenol-B+JQ1 to potently reactivate viral gene expression. PLoS Pathog 11:e1005063","journal-title":"PLoS Pathog"},{"key":"1930_CR21","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1172\/JCI92684","volume":"127","author":"NM Archin","year":"2017","unstructured":"Archin NM, Kirchherr JL, Sung JA, Clutton G, Sholtis K, Xu Y, Allard B, Stuelke E, Kashuba AD, Kuruc JD et al (2017) Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency. J Clin Invest 127:3126\u20133135","journal-title":"J Clin Invest"},{"key":"1930_CR22","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2013.09.020","volume":"155","author":"YC Ho","year":"2013","unstructured":"Ho YC, Shan L, Hosmane NN, Wang J, Laskey SB, Rosenbloom DI, Lai J, Blankson JN, Siliciano JD, Siliciano RF (2013) Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure. Cell 155:540\u2013551","journal-title":"Cell"},{"key":"1930_CR23","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1128\/JVI.01552-06","volume":"81","author":"MD Hyrcza","year":"2007","unstructured":"Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, Yang S, Wilkins O, Der SD OM (2007) Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol 81:3477\u20133486","journal-title":"J Virol"},{"key":"1930_CR24","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-4690-8-18","volume":"8","author":"JQ Wu","year":"2011","unstructured":"Wu JQ, Dwyer DE, Dyer WB, Yang YH, Wang B, Saksena NK (2011) Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease. Retrovirology 8:18","journal-title":"Retrovirology"},{"key":"1930_CR25","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1128\/JVI.01846-10","volume":"85","author":"F Vigneault","year":"2011","unstructured":"Vigneault F, Woods M, Buzon MJ, Li C, Pereyra F, Crosby SD, Rychert J, Church G, Martinez-Picado J, Rosenberg ES (2011) Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers. J Virol 85:3015\u20133019","journal-title":"J Virol"},{"key":"1930_CR26","doi-asserted-by":"crossref","first-page":"9148","DOI":"10.1128\/JVI.01297-13","volume":"87","author":"M Iglesias-Ussel","year":"2013","unstructured":"Iglesias-Ussel M, Vandergeeten C, Marchionni L, Chomont N, Romerio F (2013) High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects. J Virol 87:9148\u20139158","journal-title":"J Virol"},{"key":"1930_CR27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature21710","volume":"543","author":"B Descours","year":"2017","unstructured":"Descours B, Petitjean G, L\u00f3pez-Zaragoza JL, Bruel T, Raffel R, Psomas C, Reynes J, Lacabaratz C, Levy Y, Schwartz O et al (2017) CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses. Nature 543:564\u2013567","journal-title":"Nature"},{"key":"1930_CR28","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1038\/s41586-018-0493-4","volume":"561","author":"L P\u00e9rez","year":"2018","unstructured":"P\u00e9rez L, Anderson J, Chipman J, Thorkelson A, Chun TW, Moir S, Haase AT, Douek DC, Schacker TW, Boritz EA (2018) Conflicting evidence for HIV enrichment in CD32+ CD4 T cells. Nature 561:E9\u2013E16","journal-title":"Nature"},{"key":"1930_CR29","doi-asserted-by":"crossref","first-page":"E17","DOI":"10.1038\/s41586-018-0494-3","volume":"561","author":"LN Bertagnolli","year":"2018","unstructured":"Bertagnolli LN, White JA, Simonetti FR, Beg SA, Lai J, Tomescu C, Murray AJ, Antar AAR, Zhang H, Margolick JB et al (2018) The role of CD32 during HIV-1 infection. Nature 561:E17\u2013E19","journal-title":"Nature"},{"key":"1930_CR30","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1038\/s41586-018-0495-2","volume":"561","author":"CE Osuna","year":"2018","unstructured":"Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM et al (2018) Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature 561:E20\u2013E28","journal-title":"Nature"},{"key":"1930_CR31","doi-asserted-by":"crossref","first-page":"15541","DOI":"10.1038\/s41598-018-33749-5","volume":"8","author":"M Garc\u00eda","year":"2018","unstructured":"Garc\u00eda M, Navarrete-Mu\u00f1oz MA, Ligos JM, Cabello A, Restrepo C, L\u00f3pez-Bernaldo JC, de la Hera FJ, Barros C, Montoya M, Fernandez-Guerrero M et al (2018) CD32 Expression is not Associated to HIV-DNA content in CD4 cell subsets of individuals with Different Levels of HIV Control. Sci Rep 8:15541","journal-title":"Sci Rep"},{"key":"1930_CR32","doi-asserted-by":"crossref","unstructured":"Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genesca M, et al. (2018) CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells. Sci Transl Med 10 (437):pii: eaar6759.","DOI":"10.1126\/scitranslmed.aar6759"},{"key":"1930_CR33","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/433188","volume":"41","author":"O Lambotte","year":"2005","unstructured":"Lambotte O, Boufassa F, Madec Y, Nguyen A, Goujard C, Meyer L, Rouzioux C, Venet A, Delfraissy JF, SEROCO-HEMOCO Study Group (2005) HIV controllers: a homogeneous group of HIV1 infected patients with spontaneous control of viral replication. Clin Infect Dis 41:1053\u20131056","journal-title":"Clin Infect Dis"},{"key":"1930_CR34","volume":"7","author":"EH Graf","year":"2011","unstructured":"Graf EH, Mexas AM, Yu JJ, Shaheen F, Liszewski MK, Di Mascio M, Migueles SA, Connors M, O\u2019Doherty U (2011) Elite suppressors harbor low levels of integrated HIV DNA and high levels of 2-LTR circular HIV DNA compared to HIV+ patients on and off ART. PLoS Pathog 7:e1001300","journal-title":"PLoS Pathog"},{"key":"1930_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0b013e3182a1bc81","volume":"65","author":"MJ Buzon","year":"2014","unstructured":"Buzon MJ, Yang Y, Ouyang Z, Sun H, Seiss K, Rogich J, Le Gall S, Pereyra F, Rosenberg ES, Yu XG et al (2014) Susceptibility to CD8 T cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cells. J Acquir Immune Defic Syndr 65:1\u20139","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1930_CR36","doi-asserted-by":"crossref","first-page":"16799","DOI":"10.1038\/s41598-017-17057-y","volume":"7","author":"M Garc\u00eda","year":"2017","unstructured":"Garc\u00eda M, G\u00f3rgolas M, Cabello A, Estrada V, Ligos JM, Fern\u00e1ndez-Guerrero M, Barros C, L\u00f3pez-Bernaldo JC, de la Hera FJ, Montoya M et al (2017) Peripheral T follicular helper cells make a difference in HIV reservoir size between elite controllers and patients on successful cART. Sci Rep 7:16799","journal-title":"Sci Rep"},{"key":"1930_CR37","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1172\/JCI44539","volume":"121","author":"H Chen","year":"2011","unstructured":"Chen H, Li C, Huang J, Cung T, Seiss K, Beamon J, Carrington MF, Porter LC, Burke PS, Yang Y et al (2011) CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21. J Clin Invest 121:1549\u20131560","journal-title":"J Clin Invest"},{"key":"1930_CR38","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.chom.2014.05.011","volume":"15","author":"J Leng","year":"2014","unstructured":"Leng J, Ho HP, Buzon MJ, Pereyra F, Walker BD, Yu XG, Chang EJ, Lichterfeld M (2014) A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4 (+) T cells from elite controllers. Cell Host Microbe 15:717\u2013728","journal-title":"Cell Host Microbe"},{"key":"1930_CR39","doi-asserted-by":"crossref","first-page":"9646","DOI":"10.1128\/JVI.05327-11","volume":"85","author":"MJ Buzon","year":"2011","unstructured":"Buzon MJ, Seiss K, Weiss R, Brass AL, Rosenberg ES, Pereyra F, Yu XG, Lichterfeld M (2011) Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers. J Virol 85:9646\u20139650","journal-title":"J Virol"},{"key":"1930_CR40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175899","volume":"12","author":"S Mor\u00f3n-L\u00f3pez","year":"2017","unstructured":"Mor\u00f3n-L\u00f3pez S, Puertas MC, G\u00e1lvez C, Navarro J, Carrasco A, Esteve M, Many\u00e9 J, Crespo M, Salgado M, Martinez-Picado J (2017) Sensitive quantification of the HIV-1 reservoir in gut-associated lymphoid tissue. PLoS One 12:e0175899","journal-title":"PLoS One"},{"key":"1930_CR41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S2055-6640(20)30460-X","volume":"2","author":"W Trypsteen","year":"2016","unstructured":"Trypsteen W, Kiselinova M, Vandekerckhove L, De Spiegelaere W (2016) Diagnostic utility of droplet digital PCR for HIV reservoir quantification. J Virus Erad 2:162\u2013169","journal-title":"J Virus Erad"},{"key":"1930_CR42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymeth.2009.01.002","volume":"47","author":"MK Liszewski","year":"2009","unstructured":"Liszewski MK, Yu JJ, O\u2019Doherty U (2009) Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. Methods 47:254\u2013260","journal-title":"Methods"},{"key":"1930_CR43","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1128\/JCM.41.10.4531-4536.2003","volume":"41","author":"S Palmer","year":"2003","unstructured":"Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA et al (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol 41:4531\u20134536","journal-title":"J Clin Microbiol"},{"key":"1930_CR44","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/cid\/civ456","volume":"61","author":"M Mart\u00ednez-Bonet","year":"2015","unstructured":"Mart\u00ednez-Bonet M, Puertas MC, Fortuny C, Ouchi D, Mellado MJ, Rojo P, Noguera-Julian A, Mu\u00f1oz-Fernandez MA, Martinez-Picado J (2015) Establishment and replenishment of the viral reservoir in perinatally HIV-1-infected children initiating very early antiretroviral therapy. Clin Infect Dis 61:1169\u20131178","journal-title":"Clin Infect Dis"},{"key":"1930_CR45","doi-asserted-by":"crossref","first-page":"8604","DOI":"10.1021\/ac202028g","volume":"83","author":"BJ Hindson","year":"2011","unstructured":"Hindson BJ, Ness KD, Masquelier DA, Belgrader P, Heredia NJ, Makarewicz AJ, Bright IJ, Lucero MY, Hiddessen AL, Legler TC et al (2011) High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 83:8604\u20138610","journal-title":"Anal Chem"},{"key":"1930_CR46","doi-asserted-by":"crossref","first-page":"W117","DOI":"10.1093\/nar\/gkv384","volume":"43","author":"R Alonso","year":"2015","unstructured":"Alonso R, Salavert F, Garcia-Garcia F, Carbonell-Caballero J, Bleda M, Garcia-Alonso L, Sanchis-Juan A, Perez-Gil D, Marin-Garcia P, Sanchez R et al (2015) Babelomics 5.0: functional interpretation for new generations of genomic data. Nucleic Acids Res 43:W117\u2013W121","journal-title":"Nucleic Acids Res"},{"key":"1930_CR47","volume":"27","author":"D Montaner","year":"2010","unstructured":"Montaner D, Dopazo J (2010) Multidimensional gene set analysis of genomic data. PLoS One 27:e10348","journal-title":"PLoS One"},{"key":"1930_CR48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.4049\/jimmunol.1900396","volume":"203","author":"VC Lam","year":"2019","unstructured":"Lam VC, Folkersen L, Aguilar OA, Lanier LL (2019) KLF12 Regulates Mouse NK Cell Proliferation. J Immunol 203:981\u2013989","journal-title":"J Immunol"},{"key":"1930_CR49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/QAI.0000000000000500","volume":"68","author":"FH C\u00f4rtes","year":"2015","unstructured":"C\u00f4rtes FH, Passaes CP, Bello G, Teixeira SL, Vorsatz C, Babic D, Sharkey M, Grinsztejn B, Veloso V, Stevenson M et al (2015) HIV controllers with different viral load cutoff levels have distinct virologic and immunologic profiles. J Acquir Immune Defic Syndr 68:377\u2013385","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1930_CR50","doi-asserted-by":"crossref","first-page":"15253","DOI":"10.1038\/s41598-018-33481-0","volume":"8","author":"SK Nissen","year":"2018","unstructured":"Nissen SK, Christiansen M, Helleberg M, Kj\u00e6r K, J\u00f8rgensen SE, Gerstoft J, Katzenstein TL, Benfield T, Kronborg G, Larsen CS et al (2018) Whole exome sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules. Sci Rep 8:15253","journal-title":"Sci Rep"},{"key":"1930_CR51","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/QAD.0000000000002474","volume":"34","author":"AK Kwaa","year":"2020","unstructured":"Kwaa AK, Garliss CC, Ritter KD, Laird GM, Blankson JN (2020) Elite suppressors have low frequencies of intact HIV-1 proviral DNA. AIDS 34:641\u2013643","journal-title":"AIDS"},{"key":"1930_CR52","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/infdis\/jit667","volume":"209","author":"PD Burbelo","year":"2014","unstructured":"Burbelo PD, Bayat A, Rhodes CS, Hoh R, Martin JN, Fromentin R, Chomont N, H\u00fctter G, Kovacs JA, Deeks SG (2014) HIV antibody characterization as a method to quantify reservoir size during curative interventions. J Infect Dis 209:1613\u20131617","journal-title":"J Infect Dis"},{"key":"1930_CR53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/653677","volume":"51","author":"B Julg","year":"2010","unstructured":"Julg B, Pereyra F, Buz\u00f3n MJ, Piechocka-Trocha A, Clark MJ, Baker BM, Lian J, Miura T, Martinez-Picado J, Addo MM et al (2010) Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers. Clin Infect Dis 51:233\u2013238","journal-title":"Clin Infect Dis"},{"key":"1930_CR54","doi-asserted-by":"crossref","first-page":"ofx064","DOI":"10.1093\/ofid\/ofx064","volume":"4","author":"E Canou\u00ef","year":"2017","unstructured":"Canou\u00ef E, L\u00e9curoux C, Avettand-Feno\u00ebl V, Gousset M, Rouzioux C, Saez-Cirion A, Meyer L, Bousaffa F, Lambotte O, No\u00ebl N et al (2017) A subset of extreme human immunodeficiency virus (HIV) controllers is characterized by a small HIV blood reservoir and a weak T-cell activation level. Open Forum Infect Dis 4:ofx064","journal-title":"Open Forum Infect Dis"},{"key":"1930_CR55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2016.04.007","volume":"83","author":"G Nunnari","year":"2016","unstructured":"Nunnari G, Fagone P, Condorelli F, Nicoletti F, Malaguarnera L, Di Rosa M (2016) CD4+ T-cell gene expression of healthy donors, HIV-1 and elite controllers: immunological chaos. Cytokine 83:127\u2013135","journal-title":"Cytokine"},{"key":"1930_CR56","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12967-017-1294-5","volume":"15","author":"LL Zhang","year":"2017","unstructured":"Zhang LL, Zhang ZN, Wu X, Jiang YJ, Fu YJ, Shang H (2017) Transcriptomic meta-analysis identifies gene expression characteristics in various samples of HIV-infected patients with nonprogressive disease. J Transl Med 15:191","journal-title":"J Transl Med"},{"key":"1930_CR57","volume":"8","author":"EH Graf","year":"2013","unstructured":"Graf EH, Pace MJ, Peterson BA, Lynch LJ, Chukwulebe SB, Mexas AM, Shaheen F, Martin JN, Deeks SG, Connors M et al (2013) Gag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo. PLoS One 8:e71879","journal-title":"PLoS One"},{"key":"1930_CR58","doi-asserted-by":"crossref","first-page":"e00109","DOI":"10.1128\/JVI.00109-17","volume":"91","author":"N Alsahafi","year":"2017","unstructured":"Alsahafi N, Richard J, Pr\u00e9vost J, Coutu M, Brassard N, Parsons MS, Kaufmann DE, Brockman M, Finzi A (2017) Impaired downregulation of NKG2D ligands by Nef proteins from elite controllers sensitizes HIV-1-infected cells to antibody-dependent cellular cytotoxicity. J Virol 91:e00109\u2013e00117","journal-title":"J Virol"},{"key":"1930_CR59","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1097\/QAD.0b013e32835861b0","volume":"26","author":"C Tomescu","year":"2012","unstructured":"Tomescu C, Duh FM, Hoh R, Viviani A, Harvill K, Martin MP, Carrington M, Deeks SG, Montaner LJ (2012) Impact of protective killer inhibitory receptor\/human leukocyte antigen genotypes on natural killer cell and T-cell function in HIV-1-infected controllers. AIDS 26:1869\u20131878","journal-title":"AIDS"},{"key":"1930_CR60","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/nm.2004","volume":"15","author":"A Meier","year":"2009","unstructured":"Meier A, Chang JJ, Chan ES, Pollard RB, Sidhu HK, Kulkarni S, Wen TF, Lindsay RJ, Orellana L, Mildvan D et al (2009) Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nat Med 15:955\u2013959","journal-title":"Nat Med"},{"key":"1930_CR61","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/hep.25771","volume":"56","author":"L Golden-Mason","year":"2012","unstructured":"Golden-Mason L, Stone AE, Bambha KM, Cheng L, Rosen HR (2012) Race- and gender-related variation in natural killer p46 expression associated with differential anti-hepatitis C virus immunity. Hepatology 56:1214\u20131222","journal-title":"Hepatology"},{"key":"1930_CR62","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.1128\/JVI.00548-10","volume":"84","author":"KA O\u2019Connell","year":"2010","unstructured":"O\u2019Connell KA, Brennan TP, Bailey JR, Ray SC, Siliciano RF, Blankson JN (2010) Control of HIV-1 in elite suppressors despite ongoing replication and evolution in plasma virus. J Virol 84:7018\u20137028","journal-title":"J Virol"},{"key":"1930_CR63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/JVI.01763-08","volume":"83","author":"H Hatano","year":"2009","unstructured":"Hatano H, Delwart EL, Norris PJ, Lee TH, Dunn-Williams J, Hunt PW, Hoh R, Stramer SL, Linnen JM, McCune JM et al (2009) Evidence for persistent low-level viremia in individuals who control human immunodeficiency virus in the absence of antiretroviral therapy. J Virol 83:329\u2013335","journal-title":"J Virol"},{"key":"1930_CR64","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1086\/605446","volume":"200","author":"F Pereyra","year":"2009","unstructured":"Pereyra F, Palmer S, Miura T, Block BL, Wiegand A, Rothchild AC, Baker B, Rosenberg R, Cutrell E, Seaman MS et al (2009) Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis 200:984\u2013990","journal-title":"J Infect Dis"},{"key":"1930_CR65","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/588791","volume":"47","author":"JB Dinoso","year":"2008","unstructured":"Dinoso JB, Kim SY, Siliciano RF, Blankson JN (2008) A comparison of viral loads between HIV-1-infected elite suppressors and individuals who receive suppressive highly active antiretroviral therapy. Clin Infect Dis 47:102\u2013104","journal-title":"Clin Infect Dis"},{"key":"1930_CR66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030046","volume":"3","author":"F Maldarelli","year":"2007","unstructured":"Maldarelli F, Palmer S, King MS, Wiegand A, Polis MA, Mican J, Kovacs JA, Davey RT, Rock-Kress D, Dewar R et al (2007) ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog 3:e46","journal-title":"PLoS Pathog"},{"key":"1930_CR67","volume":"8","author":"MJ Pace","year":"2012","unstructured":"Pace MJ, Graf EH, Agosto LM, Mexas AM, Male F, Brady T, Bushman FD, O`Doherty U. (2012) Directly infected resting CD4 + T cells can produce HIV Gag without spreading infection in a model of HIV latency. PLoS Pathog 8:e1002818","journal-title":"PLoS Pathog"},{"key":"1930_CR68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/v11030200","volume":"11","author":"S Zicari","year":"2019","unstructured":"Zicari S, Sessa L, Cotugno N, Ruggiero A, Morrocchi E, Concato C, Rocca S, Zacari P, Manno EC, Palma P (2019) Immune activation, inflammation, and non-AIDS co-morbidities in HIV-infected patients under long-term ART. Viruses 11:200","journal-title":"Viruses"},{"key":"1930_CR69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S2055-6640(20)30046-7","volume":"5","author":"NY Gebara","year":"2019","unstructured":"Gebara NY, El Kamari V, Rizk N (2019) HIV-1 elite controllers: an immunovirological review and clinical perspectives. J Virus Erad 5:163\u2013166","journal-title":"J Virus Erad"},{"key":"1930_CR70","doi-asserted-by":"crossref","first-page":"e78644","DOI":"10.1371\/journal.pone.0078644","volume":"9","author":"S Zhao","year":"2014","unstructured":"Zhao S, Fung-Leung WP, Bittner A, Ngo K, Liu X (2014) Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS One 9:e78644","journal-title":"PLoS One"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01930-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01930-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T23:29:36Z","timestamp":1623886176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01930-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,17]]},"references-count":70,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1930"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01930-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,17]]},"assertion":[{"value":"20 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}